{"id":14768,"date":"2016-11-02T12:04:30","date_gmt":"2016-11-02T11:04:30","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=14768"},"modified":"2021-10-14T12:06:48","modified_gmt":"2021-10-14T10:06:48","slug":"ortega-joaquin-n-echave-m-oyaguez-i-garrido-p-felip-e-trigo-j-filori-m-gonzalez-p","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/ortega-joaquin-n-echave-m-oyaguez-i-garrido-p-felip-e-trigo-j-filori-m-gonzalez-p\/","title":{"rendered":"Ortega-Joaquin N, Echave M, Oyag\u00fcez I, Garrido P, Felip E, Trigo J, Filori M, Gonz\u00e1lez P"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/>Ortega-Joaquin N, Echave M, Oyag\u00fcez I, Garrido P, Felip E, Trigo J, Filori M, Gonz\u00e1lez P<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6 style=\"text-align: justify;\">Cost-analysis for toxicity management in advanced squamous non-small cell lung cancer: nivolumab vs docetaxel<\/h6>\n<h6 style=\"text-align: justify;\"><strong>19th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Viena, Austria. 29 oct- 2 nov 2016<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/10\/185.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ortega-Joaquin N, Echave M, Oyag\u00fcez I, Garrido P, Felip E, Trigo J, Filori M, Gonz\u00e1lez P &nbsp; &nbsp; Cost-analysis for toxicity management in advanced squamous non-small cell lung cancer: nivolumab vs docetaxel 19th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Viena, Austria. 29 oct- 2 nov 2016 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[937,928,246],"tags":[],"class_list":["post-14768","post","type-post","status-publish","format-quote","hentry","category-amc-ac-tipo-de-proyecto","category-oncologia","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14768"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=14768"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14768\/revisions"}],"predecessor-version":[{"id":14770,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14768\/revisions\/14770"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=14768"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=14768"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=14768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}